when taking tirzepatide What to Expect on Tirzepatide: Month-by-Month Weight Loss Timeline Tirzepatide reduces appetite, food cravings

Semaglutide is a GLP-1 agonist, a physiological regulator of appetite and caloric intake

Ask your doctor about anti-nausea medications if symptoms persist

See a doctor if: Symptoms last longer than about a week, worsen, or appear with fever, swollen glands, difficulty swallowing, breathing problems, or severe pain

FDA approves first generic of once-daily GLP-1 injection to lower blood sugar in patients with Type 2 diabetes, FDA (2024) FDA drug shortages, FDA (2024) Hikma receives FDA approval and launches the generic version of Victoza, Liraglutide, in the U.S., Hikma (2024) How Victoza works, Novo Nordisk Liraglutide injection, MedLinePlus (2021) Special report: Potential strategies for addressing GLP-1 and dual GLP-1/GIP receptor agonist shortages, Clinical Diabetes (2023) Type 2 diabetes, CDC (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

Factors associated with response to teduglutide in patients with short-bowel syndrome and intestinal failure

Relaxation exercises, mindfulness practices, and adequate sleep support overall wellbeing and may reduce symptom severity